abstract |
The present invention involves the topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient, a) a method of treating telangiectasia, b) treating inflammatory lesions And c) a method of treating two or more rosacea symptoms selected from erythema, telangiectasia, or inflammatory lesions. [Selection] Figure 1 |